XENETIC BIOSCIENCES, INC. Prepaid Expense and Other Assets
XENETIC BIOSCIENCES, INC. (XBIO) had Prepaid Expense and Other Assets of $400.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2024-03-21
- 2023-12-31: Prepaid Expense and Other Assets $400.00K.
- 2023-09-30: Prepaid Expense and Other Assets $300.00K.
- 2023-06-30: Prepaid Expense and Other Assets $37.00K.
- 2022-12-31: Prepaid Expense and Other Assets $300.00K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2023-12-31 | $400.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $37.00K 10-Q · filed 2023-08-10 |
| 2022-12-31 | $300.00K 10-K · filed 2023-03-22 |
| 2021-12-31 | $300.00K 10-K · filed 2022-03-22 |
| 2020-12-31 | $200.00K 10-K · filed 2022-03-22 |
| 2019-12-31 | $700.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |